首页> Cancer letters> Corrigendum to "cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells" [Canc. Lett. 403 (2017) 260-270].

Corrigendum to "cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells" [Canc. Lett. 403 (2017) 260-270].

导出 LinkOut

翻译打印收藏纠错

第一作者： Hui,Fu

第一单位： Department of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China; The Key Laboratory of Tianjin Cancer Prevention and Treatment, National Clinical Research Center for Cancer, Tianjin, 300060, China; Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.

作者： Hui,Fu ^[1] ; Yuchao,He ^[2] ; Lisha,Qi ^[3] ; Lu,Chen ^[2] ; Yi,Luo ^[2] ; Liwei,Chen ^[2] ; Yongmei,Li ^[4] ; Ning,Zhang ^[2] ; Hua,Guo ^[5]

作者单位： Department of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China; The Key Laboratory of Tianjin Cancer Prevention and Treatment, National Clinical Research Center for Cancer, Tianjin, 300060, China; Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China. ^[1] Department of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China; The Key Laboratory of Tianjin Cancer Prevention and Treatment, National Clinical Research Center for Cancer, Tianjin, 300060, China. ^[2] Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China; The Key Laboratory of Tianjin Cancer Prevention and Treatment, National Clinical Research Center for Cancer, Tianjin, 300060, China. ^[3] Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China. ^[4] Department of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China; The Key Laboratory of Tianjin Cancer Prevention and Treatment, National Clinical Research Center for Cancer, Tianjin, 300060, China. Electronic address: guohua@tjmuch.com. ^[5]

DOI 10.1016/j.canlet.2020.11.009

PMID 33221059

发布时间 2020-12-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交